Printer Friendly

CNS, INC. REPORTS THIRD QUARTER RESULTS

 MINNEAPOLIS, Nov. 3 /PRNewswire/ -- CNS, Inc. (NASDAQ: CNXS) today reported third quarter sales and earnings. For the third quarter ended Sept. 30, 1993, the company reported sales of $1,660,972 compared to $2,063,547 for the same period of 1992. The net loss for the quarter was $198,276 or $.03 per share, compared to net earnings of $51,432 or $.01 per share for the comparable third quarter of 1992.
 For the nine months ended Sept. 30, 1993, sales were $5,379,564 compared to $5,306,288 for the corresponding nine months of 1992. A net loss of $836,695 or $.13 per share was reported for the nine month period of 1993 versus a net loss of $714,589 or $.12 per share for the comparable nine month period of 1992.
 Richard E. Jahnke, president and chief operating officer, said that despite the reductions in sales during the third quarter of 1993, the dollar value of orders received was consistent with the corresponding quarter of 1992. The major difference noted was the product mix which included orders for the new sleep diagnostic products with delivery scheduled for the fourth quarter of 1993.
 Jahnke also stated that on Oct. 12, 1993, the U.S. Food and Drug Administration notified CNS that marketing activities could begin on the Breathe Right(TM) device, an external nasal dilator which enhances nasal breathing without the use of drugs. Orders and shipments of this product began in late October, 1993.
 CNS, Inc., based in Minneapolis, designs, manufactures and markets medical devices used principally in the diagnosis and treatment of sleep disorders.
 CNS, INC.
 FINANCIAL HIGHLIGHTS
 (Unaudited)
 Three Months Ended Nine Months Ended
 9/30/93 9/30/92 9/30/93 9/30/92
 Sales $1,660,972 $2,063,547 $5,379,564 $5,306,288
 Net earnings (loss) $(198,276) $51,432 $(836,695) $(714,589)
 Net earnings (loss) per
 common and common
 equivalent shares $(.03) $.01 $(.13) $(.12)
 Weighted average number
 of common and common
 equivalent shares
 outstanding: 6,577,462 6,558,692 6,567,221 5,999,887
 -0- 11/3/93
 /CONTACT: Daniel E. Cohen, M.D., chief executive officer of CNS, 612-474-7600/
 (CNXS)


CO: CNS, Inc. ST: Minnesota IN: MTC SU: ERN

DB-CP -- MN023 -- 0338 11/03/93 17:13 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 3, 1993
Words:387
Previous Article:IES INDUSTRIES DECLARES DIVIDEND
Next Article:SUNRISE LEASING ANNOUNCES RECORD REVENUES AND NET INCOME FOR SECOND QUARTER
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters